Growth Metrics

BioNTech SE (BNTX) EBT Margin (2018 - 2025)

BioNTech SE (BNTX) posted EBT Margin of 25.06% for Q4 2025, down 1641.08% on a QoQ basis from 1.63% in Q3 2025, and down 5037.0% year-over-year from 0.51% in Q4 2024.

BioNTech SE (BNTX) has 8 years of EBT Margin data on file, last reported at 25.06% in Q4 2025.

  • In Q4 2025, EBT Margin fell 5037.0% year-over-year to 25.06%; the TTM figure through Dec 2025 stood at 34.95% (down 951.0% YoY), while the FY2025 annual figure was 36.61%, up 60273.0% from the prior year.
  • EBT Margin declined to 25.06% in Q4 2025, from 1.63% in the prior quarter.
  • Across five years, EBT Margin topped out at 85.2% in Q4 2021 and bottomed at 2456.71% in Q2 2024.
  • A 5-year average of 126.16% and a median of 35.12% in 2023 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2024 — EBT Margin plunged 221091 bps — and 2025, when it surged 230230 bps.
  • Year by year, EBT Margin stood at 85.2% in 2021, then declined by 13 bps to 74.16% in 2022, then slumped by 40 bps to 44.84% in 2023, then slumped by 44 bps to 25.31% in 2024, then tumbled by 199 bps to 25.06% in 2025.
  • The last three EBT Margin figures came in at 25.06% (Q4 2025), 1.63% (Q3 2025), and 154.41% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -6.40%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 41.95%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 23.05%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 18.99%
10 BioNTech SE 27.66 Bn 7.53 Bn 668.28 Mn -25.06%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -25.06%
Sep 30, 2025 1.63%
Jun 30, 2025 -154.41%
Mar 31, 2025 -1,919.83%
Dec 31, 2024 9,127.27%
Sep 30, 2024 12.75%
Jun 30, 2024 -2,456.71%
Mar 31, 2024 -3,606.52%
Dec 31, 2023 44.84%
Sep 30, 2023 25.40%
Jun 30, 2023 -245.80%
Mar 31, 2023 55.42%
Dec 31, 2022 74.16%
Sep 30, 2022 70.61%
Jun 30, 2022 72.56%
Mar 31, 2022 78.72%
Dec 31, 2021 85.20%
Sep 30, 2021 76.67%
Jun 30, 2021 75.78%
Mar 31, 2021 80.17%
Sep 30, 2020 307.41%
Jun 30, 2020 216.70%
Mar 31, 2020 192.78%
Sep 30, 2019 105.00%
Jun 30, 2019 194.19%
Mar 31, 2019 155.83%
Dec 31, 2018 -72.37%
Sep 30, 2018 112.30%